Rocket Pharmaceuticals Announces Appointment of Mikael Dolsten, M.D., Ph.D., to Board of Directors
| RCKT Stock | USD 14.41 0.02 0.14% |
Slightly above 62% of Rocket Pharmaceuticals' investor base is looking to short. The analysis of the overall investor sentiment regarding Rocket Pharmaceuticals suggests that many traders are alarmed. Rocket Pharmaceuticals' investing sentiment can be driven by a variety of factors including economic data, Rocket Pharmaceuticals' earnings reports, geopolitical events, and overall market trends.
Rocket |
Rocket Pharmaceuticals, Inc. , a fully integrated, late-stage biotechnology company advancing a sustainable pipeline of genetic therapie
Read at businesswire.com
 |
Rocket Pharmaceuticals Fundamental Analysis
We analyze Rocket Pharmaceuticals' financials across various querterly and yearly statements, indicators and fundamental ratios. We help investors to determine the real value of Rocket Pharmaceuticals using virtually all public information available. We use both quantitative as well as qualitative analysis to arrive at the intrinsic value of Rocket Pharmaceuticals based on its fundamental data. In general, a quantitative approach, as applied to this company, focuses on analyzing financial statements comparatively, whereas a qaualitative method uses data that is important to a company's growth but cannot be measured and presented in a numerical way.
Working Capital
Working Capital Comparative Analysis
Rocket Pharmaceuticals is currently under evaluation in working capital category among its peers. Working Capital is a measure of company efficiency and operating liquidity. The working capital is usually calculated by subtracting Current Liabilities from Current Assets. It is an important indicator of the firm ability to continue its normal operations without additional debt obligations. .
Rocket Pharmaceuticals Potential Pair-trading
One of the popular trading techniques among algorithmic traders is to use market-neutral strategies where every trade hedges away some risk. Because there are two separate transactions required, even if one position performs unexpectedly, the other equity can make up some of the losses. Below are some of the equities that can be combined with Rocket Pharmaceuticals stock to make a market-neutral strategy. Peer analysis of Rocket Pharmaceuticals could also be used in its relative valuation, which is a method of valuing Rocket Pharmaceuticals by comparing valuation metrics with similar companies.
Peers
Rocket Pharmaceuticals Related Equities
| QURE | Uniqure NV | 19.43 | ||||
| PLRX | Pliant Therapeutics | 12.39 | ||||
| MRUS | Merus BV | 8.23 | ||||
| STRO | Sutro Biopharma | 3.77 | ||||
| INZY | Inozyme Pharma | 2.95 | ||||
| SLDB | Solid Biosciences | 1.58 | ||||
| RGNX | Regenxbio | 0.81 | ||||
| MIRM | Mirum Pharmaceuticals | 0.02 | ||||
| SNDX | Syndax Pharmaceuticals | 0.12 | ||||
| STOK | Stoke Therapeutics | 0.33 | ||||
| DAWN | Day One | 0.65 | ||||
| MGTX | MeiraGTx Holdings | 1.92 | ||||
| RYTM | Rhythm Pharmaceuticals | 1.93 | ||||
| LRMR | Larimar Therapeutics | 2.05 | ||||
| CYTK | Cytokinetics | 2.37 | ||||
| VRDN | Viridian Therapeutics | 2.55 | ||||
| PCVX | Vaxcyte | 2.90 | ||||
| REPL | Replimune | 3.76 | ||||
| DYN | Dyne Therapeutics | 4.34 | ||||
| RVMD | Revolution Medicines | 10.46 |
Additional Tools for Rocket Stock Analysis
When running Rocket Pharmaceuticals' price analysis, check to measure Rocket Pharmaceuticals' market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy Rocket Pharmaceuticals is operating at the current time. Most of Rocket Pharmaceuticals' value examination focuses on studying past and present price action to predict the probability of Rocket Pharmaceuticals' future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move Rocket Pharmaceuticals' price. Additionally, you may evaluate how the addition of Rocket Pharmaceuticals to your portfolios can decrease your overall portfolio volatility.